Upfront surgical organ-preservation strategy in advanced-stage laryngeal cancer

Research output: Contribution to journalArticlepeer-review


PURPOSE: Advanced-stage laryngeal cancer is a challenging disease that needs multimodal treatment. Medical and surgical organ-preservation strategies have been developing in the last decades to spare these functions while granting cancer cure. The current work presents the experience of a tertiary-care center in conservative surgery for advanced-stage laryngeal cancer.

MATERIALS AND METHODS: We collected clinical data of patients submitted to open partial horizontal laryngectomies (OPHLs) and any possible adjuvant treatment from 2005 to 2018. Outcomes were also compared to the most recent studies reporting on both medical and surgical organ-preservation strategies.

RESULTS: One hundred ten patients were included in the analysis. Adjuvant therapy was employed in 51% of cases. The local control rate was 96.4%, while overall survival (OS) was 67%, and laryngo-esophageal dysfunction free survival (LEDFS) was 66%. Stage IV and vascular invasion were associated with a statistically-significant worse survival.

CONCLUSIONS: OPHLs are valid as upfront treatment in fit patients affected by advanced-stage laryngeal cancer. Disease control and function preservation are granted in a significant percentage of cases, even when followed by adjuvant therapy.

Original languageEnglish
Pages (from-to)103272
JournalAmerican Journal of Otolaryngology - Head and Neck Medicine and Surgery
Issue number1
Publication statusPublished - Jan 2022


Dive into the research topics of 'Upfront surgical organ-preservation strategy in advanced-stage laryngeal cancer'. Together they form a unique fingerprint.

Cite this